| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ARL5C | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-13 |
| mRNA | TRAT1 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
| mRNA | FGF6 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-12 |
| mRNA | CAPSL | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-12 |
| mRNA | ARHGAP19 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-11 |
| mRNA | SPATA5 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | LCT | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-11 |
| mRNA | KIF3A | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-11 |
| mRNA | DENND3 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-10 |
| mRNA | ADAMTS17 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-10 |
